×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MAZE – maze therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MAZE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/13
06:18 am
maze
Maze Therapeutics (MAZE) was upgraded by Mizuho to "strong-buy".
Medium
Report
Maze Therapeutics (MAZE) was upgraded by Mizuho to "strong-buy".
3/10
08:03 am
maze
Maze Therapeutics (MAZE) is now covered by Mizuho. They set an "outperform" rating and a $97.00 price target on the stock.
High
Report
Maze Therapeutics (MAZE) is now covered by Mizuho. They set an "outperform" rating and a $97.00 price target on the stock.
3/9
08:03 am
maze
Maze Therapeutics (MAZE) had its "buy" rating reaffirmed by BTIG Research. They now have a $46.00 price target on the stock.
Low
Report
Maze Therapeutics (MAZE) had its "buy" rating reaffirmed by BTIG Research. They now have a $46.00 price target on the stock.
3/4
08:44 am
maze
Maze Therapeutics (MAZE) had its price target raised by Guggenheim from $46.00 to $58.00. They now have a "buy" rating on the stock.
Low
Report
Maze Therapeutics (MAZE) had its price target raised by Guggenheim from $46.00 to $58.00. They now have a "buy" rating on the stock.
2/25
07:00 am
maze
Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
Low
Report
Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
2/16
02:12 am
maze
Maze Therapeutics Chief Medical Officer Sells 15K Shares As Company's Stock Continues to Surge [Yahoo! Finance]
Low
Report
Maze Therapeutics Chief Medical Officer Sells 15K Shares As Company's Stock Continues to Surge [Yahoo! Finance]
2/14
07:51 pm
maze
Maze Therapeutics (MAZE) Valuation Check After Strong 1 Year Shareholder Return [Yahoo! Finance]
Low
Report
Maze Therapeutics (MAZE) Valuation Check After Strong 1 Year Shareholder Return [Yahoo! Finance]
2/7
02:07 am
maze
Maze Therapeutics (NASDAQ:MAZE) was downgraded by analysts at Wall Stree
Medium
Report
Maze Therapeutics (NASDAQ:MAZE) was downgraded by analysts at Wall Stree
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/12
04:51 pm
maze
Form 4 Maze Therapeutics, Inc. For: Mar 10 Filed by: Bernstein Harold
Medium
Report
Form 4 Maze Therapeutics, Inc. For: Mar 10 Filed by: Bernstein Harold
3/10
04:33 pm
maze
Form 144 Maze Therapeutics, Inc. Filed by: Bernstein Harold
Low
Report
Form 144 Maze Therapeutics, Inc. Filed by: Bernstein Harold
3/3
04:46 pm
maze
Form 4 Maze Therapeutics, Inc. For: Feb 27 Filed by: Dandekar Atul
Medium
Report
Form 4 Maze Therapeutics, Inc. For: Feb 27 Filed by: Dandekar Atul
3/3
04:45 pm
maze
Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Bachrodt Amy
Medium
Report
Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Bachrodt Amy
3/3
04:45 pm
maze
Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Bernstein Harold
Medium
Report
Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Bernstein Harold
3/3
04:42 pm
maze
Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Tahir Misbah
Medium
Report
Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Tahir Misbah
3/3
04:33 pm
maze
Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Courtney Phillips
Medium
Report
Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Courtney Phillips
3/3
04:24 pm
maze
Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Coloma Jason V
Medium
Report
Form 4 Maze Therapeutics, Inc. For: Mar 02 Filed by: Coloma Jason V
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: